[Epithelioid sarcoma. Immunohistochemical study. Therapy with recombinant alfa interferon].
A case of Epithelioid Sarcoma in a 26 years old woman is reported. Clinical aspects of this entity are commented. Immunomarcation with monoclonal and policlonal antibodies was made, the findings were compared to those of the literature. Supervivence of the patient for 6 years without agressive surgery is remarked. Treatment was ruled out with recombinant alfa interferon for the last 3 years.
Porta
J
J
Unidad de Dermatología, Policlínico Bancario, Buenos Aires, Argentina.
Azcune
R
R
Ardura
A E
AE
Arra
A
A
Gatti
C F
CF
D000328:Adult; D001132:Arm; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007370:Interferon Type I / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012509:Sarcoma / Q000737:chemistry / Q000473:pathology / Q000628:therapy; D012878:Skin Neoplasms / Q000737:chemistry / Q000473:pathology / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000737:chemistry / Q000473:pathology / Q000628:therapy
D007370:Interferon Type I; D011994:Recombinant Proteins
Sarcoma epitelioide. Estudio inmunohistoquímico. Terapéutica con interferón alfa recombinante.